Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000656893 | SCV000211271 | likely benign | not provided | 2021-01-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25111426, 28135145) |
Ambry Genetics | RCV000160662 | SCV000212768 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000656893 | SCV000230040 | uncertain significance | not provided | 2014-11-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082336 | SCV000283697 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV003323296 | SCV000837876 | benign | Hereditary nonpolyposis colon cancer | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160662 | SCV000902890 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780471 | SCV000917744 | likely benign | not specified | 2022-07-01 | criteria provided, single submitter | clinical testing | Variant summary: MSH6 c.1054G>A (p.Val352Ile) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251198 control chromosomes, predominantly at a frequency of 0.00029 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in MSH6 causing Lynch Syndrome phenotype (0.00014), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.1054G>A has been reported in the literature in individuals affected with Hereditary Nonpolyposis Colorectal Cancer or breast cancer. However, a recent case-control study indicates that this variant is not associated with breast cancer (Dorling_2021). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (likely benign n=5, VUS n=4). Based on the evidence outlined above, the variant was classified as likely benign. |
Illumina Laboratory Services, |
RCV000986713 | SCV001297401 | uncertain significance | Lynch syndrome 5 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000656893 | SCV001469561 | likely benign | not provided | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV000656893 | SCV002010121 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000160662 | SCV004014883 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-06-15 | criteria provided, single submitter | clinical testing |